4.4 Article

Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants

期刊

JAMA PEDIATRICS
卷 169, 期 12, 页码 1105-1111

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jamapediatrics.2015.2380

关键词

-

资金

  1. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the NIH [5T32HD060558]
  2. National Center for Advancing Translational Sciences of the NIH [UL1TR001117]
  3. NICHD [HHSN275201000003I, 1R01-HD081044-01]
  4. US Food and Drug Administration [1R18-FD005292-01]
  5. NIH [K24-AI093969, R01-AI068804, 2K24HD058735-06]
  6. NIH Antibiotic Resistant Leadership Group [UM1AI104681]
  7. National Center for Advancing Translational Sciences [UL1TR001117]
  8. National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272201500006I]
  9. NIAID [R03AI117169]
  10. Agency for Healthcare and Research Quality [R01HS022872]

向作者/读者索取更多资源

IMPORTANCE Staphylococcus aureus is a frequent cause of infection in hospitalized infants. These infections are associated with increased mortality and morbidity and longer hospital stays, but data on the burden of S aureus disease in hospitalized infants are limited. OBJECTIVES To compare demographics and mortality of infants with invasive methicillin-resistant S aureus (MRSA) and methicillin-susceptible S aureus (MSSA), to determine the annual proportion of S aureus infections that were MRSA, and to contrast the risk of death after an invasive MRSA infection with the risk after an invasive MSSA infection. DESIGN, SETTING, AND PARTICIPANTS Multicenter retrospective study of a large, nationally representative cohort at 348 neonatal intensive care units managed by the Pediatrix Medical Group. Participants were 3888 infants with an invasive S aureus infection who were discharged from calendar year 1997 through calendar year 2012. EXPOSURE Invasive S aureus infection. MAIN OUTCOMES AND MEASURES The incidence of invasive S aureus infections, as well as infant characteristics and mortality after MRSA or MSSA infection. RESULTS The 3888 infants had 3978 invasive S aureus infections (2868 MSSA and 1110 MRSA). The incidence of invasive S aureus infection was 44.8 infections per 10 000 infants. The yearly proportion of invasive infections caused by MRSA increased from calendar year 1997 through calendar year 2006 and has moderately decreased since then. Infants with invasive MRSA or MSSA infections had similar gestational ages and birth weights. Invasive MRSA infections occurred more often at a younger postnatal age. For infants with available mortality data, more infants with invasive MSSA infections (n = 237) died before hospital discharge than infants with invasive MRSA infections (n = 110). The proportions of infants who died after invasive MSSA and MRSA infections were similar at 237 of 2474 (9.6%) and 110 of 926 (11.9%), respectively (P = .05). The adjusted risk of death before hospital discharge was similar after invasive MSSA and MRSA infections (risk ratio, 1.19; 95% CI, 0.96-1.49). The risks of death at 7 and 30 days after invasive infection were similar between infants with invasive MSSA infection and infants with invasive MRSA infection. CONCLUSIONS AND RELEVANCE Infant mortality after invasive MRSA and MSSA infections is similar, but MSSA causes more infections and more deaths in infants than MRSA. Measures to prevent S aureus infection should include MSSA in addition to MRSA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据